Anuh Pharma (ANUHPHR.NS) Stock Price
Anuh Pharma Price
Over the last 19 years Anuh Pharma grew revenue by 12.5% annually, reaching 7.72 B INR. Earnings per share have grown at 9.8% per year over the last 19 years. For Anuh Pharma, the net margin of 5.3% is broadly stable versus 6.3% a few years ago. At today's price the dividend yield works out to roughly 1.84%. The payout ratio is around 22% of earnings.
Anuh Pharma stock price
Anuh Pharma business model & stock analysis
Frequently asked questions about Anuh Pharma
7 analysts currently rate the Anuh Pharma stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Anuh Pharma share trades at 0.75 EUR (81.32 INR).
The revenue of Anuh Pharma is 7.72 B INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Anuh Pharma is 410.46 M INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Anuh Pharma is currently 19.86. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Anuh Pharma stock.
The price-to-sales ratio (P/S) of Anuh Pharma is currently 1.06. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Anuh Pharma stock.
The Eulerpool Quality Score for Anuh Pharma is 5/10.
The ISIN of Anuh Pharma is INE489G01022. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Anuh Pharma is ANUHPHR.NS. The ticker symbol is used to trade Anuh Pharma shares on the stock exchange.
Anuh Pharma stock
Anuh Pharma Peer Group
Anuh Pharma FIGI
All fundamentals and in-depth analysis of Anuh Pharma
Our stock analysis for Anuh Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Anuh Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.